A state judge in Maine ordered Goveror Paul LePage’s administration to stop stalling and implement a Medicaid expansion; the National Institutes of Health reported on a treatment that eradicated cancer from a patient who had untreatable, advanced breast cancer; citing changes to the Affordable Care Act, insurers are proposing double-digit rate hikes for 2019.
A state judge in Maine ordered Governor Paul LePage’s administration to stop stalling and implement Medicaid expansion, which passed through public referendum, The New York Times reported. Medicaid expansion advocates sued the LePage administration in April after it failed to submit a plan to the federal government. LePage, a Republican, has said the state doesn’t have the money to pay for it. In her ruling, Justice Michaela Murphy ordered the LePage administration to update the terms of its Medicaid program by June 11 and to provide coverage to the newly eligible beneficiaries by July 2.
The National Institutes of Health (NIH) reported on a treatment that eradicated cancer from a patient who had untreatable, advanced breast cancer. But NPR said the immunotherapy treatment, which helped 7 of 45 patients, is not yet ready for widespread use. The NIH doctors sequenced the genomes of tumors to find mutations, then tested immune cells extracted from the cancers to identify which ones might recognize the defects. Those cells were expanded by the billions in the lab, creating immune system cells known as T cells that fought those mutations.
Citing recent and upcoming changes to the Affordable Care Act (ACA) insurers in New York and Washington state are proposing double-digit rate hikes for 2019. The Hill reported that 14 New York insurers are asking state regulators to approve an average rate hike of 24%, while 11 insurers in Washington want to raise premiums by an average of 19.08%. New York attributed the proposed increases to Congress's repeal of the individual mandate. Washington state blamed uncertainty over the Trump administration's proposed ACA changes.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More